nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A bayesian approach to sample size determination in phase II cancer clinical trials
|
Sylvester, Richard J. |
|
1984 |
5 |
3 |
p. 305- 1 p. |
artikel |
2 |
A computerized inventory control system for the management of study drugs and devices
|
Collins, Dorthea |
|
1984 |
5 |
3 |
p. 309-310 2 p. |
artikel |
3 |
A covariate model for repeated binary responses
|
Muenz, Larry R. |
|
1984 |
5 |
3 |
p. 297- 1 p. |
artikel |
4 |
Adherence measures in the aspirin myocardial infarction study (AMIS)
|
Verter, Joel |
|
1984 |
5 |
3 |
p. 306- 1 p. |
artikel |
5 |
Analyses of morbidity with death as a competing risk
|
Seigel, Daniel |
|
1984 |
5 |
3 |
p. 297- 1 p. |
artikel |
6 |
An elegant new assay of drug-induced eye irritation
|
Scoville, B. |
|
1984 |
5 |
3 |
p. 296-297 2 p. |
artikel |
7 |
An evaluation of the data validation system in a multicenter clinical trial
|
Jackson, Melvin R. |
|
1984 |
5 |
3 |
p. 312- 1 p. |
artikel |
8 |
Angina scoring method in the VA CABG study
|
Peduzzi, Peter |
|
1984 |
5 |
3 |
p. 291- 1 p. |
artikel |
9 |
An interactive approach to sequential treatment assignment
|
Lee, Jeannette Y. |
|
1984 |
5 |
3 |
p. 295- 1 p. |
artikel |
10 |
An investigation of the validity of comparing noncurrent treatments
|
Reading, James C. |
|
1984 |
5 |
3 |
p. 308- 1 p. |
artikel |
11 |
Announcements
|
|
|
1984 |
5 |
3 |
p. 317-319 3 p. |
artikel |
12 |
A note on data monitoring, incomplete data and curtailed testing
|
Pasternack, Bernard S. |
|
1984 |
5 |
3 |
p. 217-222 6 p. |
artikel |
13 |
APL programs for outcome probabilities and confidence limits in sequential binomial trials
|
Larsen, Severin Olesen |
|
1984 |
5 |
3 |
p. 245-249 5 p. |
artikel |
14 |
A randomized clinical trial of brain resuscitation following cardiac arrest
|
Kelsey, S.F. |
|
1984 |
5 |
3 |
p. 292- 1 p. |
artikel |
15 |
Ascertainment system for morbidity and mortality follow-up of SHEP participants
|
Harvey, S. |
|
1984 |
5 |
3 |
p. 313- 1 p. |
artikel |
16 |
A simple ECG abnormality coding device applicable in multicenter trials
|
Kerkkamp, H.J.J. |
|
1984 |
5 |
3 |
p. 292- 1 p. |
artikel |
17 |
A survey of nursing roles in clinical trials
|
Smith, Jacqueline |
|
1984 |
5 |
3 |
p. 294- 1 p. |
artikel |
18 |
A system to check eligibility in a randomized clinical trial with complicated admission criteria
|
Tijssen, J.G.P. |
|
1984 |
5 |
3 |
p. 313-314 2 p. |
artikel |
19 |
Berkson's bias and simpson's paradox are the same fallacy in the analysis of cross-classified categorical data
|
Terrin, Michael L. |
|
1984 |
5 |
3 |
p. 301- 1 p. |
artikel |
20 |
Biased estimates of treatment effect in randomized trials
|
Gail, Mitchell |
|
1984 |
5 |
3 |
p. 303- 1 p. |
artikel |
21 |
Bias, Maximum likelihood estimators, and sequential clinical trials
|
Dupont, William D. |
|
1984 |
5 |
3 |
p. 275-277 3 p. |
artikel |
22 |
Branch vein occlusion study
|
Mead, L. |
|
1984 |
5 |
3 |
p. 292-293 2 p. |
artikel |
23 |
Cancer research campaign clinical trials centre—its contribution to improved clinical trial methodology
|
Houghton, Joan |
|
1984 |
5 |
3 |
p. 308- 1 p. |
artikel |
24 |
Changing the protocol: A case report from the macular photocoagulation study
|
|
|
1984 |
5 |
3 |
p. 203-216 14 p. |
artikel |
25 |
Clinical trial results: Impact on clinician
|
Probstfield, Jeffrey L. |
|
1984 |
5 |
3 |
p. 301- 1 p. |
artikel |
26 |
Clinical trials and medical practice: Methodological considerations
|
Hasford, Joerg |
|
1984 |
5 |
3 |
p. 300- 1 p. |
artikel |
27 |
Clinical trials and medical technologies assessment. The experience of the CEDIT
|
Durieux, Pierre |
|
1984 |
5 |
3 |
p. 300- 1 p. |
artikel |
28 |
Comparability of randomized groups
|
Altman, Douglas G. |
|
1984 |
5 |
3 |
p. 297- 1 p. |
artikel |
29 |
Competency-based survey method for assessing physician clinical trial knowledge and skills
|
Russell, Michael L. |
|
1984 |
5 |
3 |
p. 300-301 2 p. |
artikel |
30 |
Computer-assisted protocol monitoring in trials with complex treatment protocols: The SHEP study
|
Fox, C. |
|
1984 |
5 |
3 |
p. 304- 1 p. |
artikel |
31 |
Coordinator turnover in the macular photocoagulation study
|
Optican, Donna C. |
|
1984 |
5 |
3 |
p. 294- 1 p. |
artikel |
32 |
Cost-effective choice of accural and follow-up periods for clinical trials
|
Morgan, Timothy M. |
|
1984 |
5 |
3 |
p. 312- 1 p. |
artikel |
33 |
Current management questionnaires and protocol design
|
Riley, Diana L. |
|
1984 |
5 |
3 |
p. 309- 1 p. |
artikel |
34 |
Design considerations in randomized crossover trials
|
Lubsen, J. |
|
1984 |
5 |
3 |
p. 296- 1 p. |
artikel |
35 |
Design of a data entry package for clinical trials
|
Aus, Berit Marie |
|
1984 |
5 |
3 |
p. 311- 1 p. |
artikel |
36 |
Development of methodology to aid participation in colorectal cancer marker study
|
Lennon, Christina A. |
|
1984 |
5 |
3 |
p. 309- 1 p. |
artikel |
37 |
Distributed data processing as a clinical management tool in collaborative trials: The SHEP study
|
Remijas, T. |
|
1984 |
5 |
3 |
p. 313- 1 p. |
artikel |
38 |
Effects of cholestyramine treatment on progression of coronary atherosclerosis: The NHLBI type II coronary intervention study
|
Kelsey, S.F. |
|
1984 |
5 |
3 |
p. 292- 1 p. |
artikel |
39 |
Estimating the length of two-armed randomized survival trials using a survival density that allows for cure
|
Sposto, Richard |
|
1984 |
5 |
3 |
p. 303- 1 p. |
artikel |
40 |
Ethical and design considerations in a randomized trial of the effect of steroid vs. placebo therapy in severe sepsis
|
Peduzzi, Peter |
|
1984 |
5 |
3 |
p. 293-294 2 p. |
artikel |
41 |
Factorial designs for randomized trials
|
Byar, David P. |
|
1984 |
5 |
3 |
p. 296- 1 p. |
artikel |
42 |
Fifth annual meeting Society for clinical trials
|
|
|
1984 |
5 |
3 |
p. 279-290 12 p. |
artikel |
43 |
Fully informed consent: The diabetes control and complications trial approach to the informed consent process
|
|
|
1984 |
5 |
3 |
p. 293- 1 p. |
artikel |
44 |
Generalized data management systems: Report on operational experiences
|
Singer, Stephen W. |
|
1984 |
5 |
3 |
p. 303- 1 p. |
artikel |
45 |
Graphic formats to display trends in adherence behavior changes
|
Newman, Barbara |
|
1984 |
5 |
3 |
p. 311- 1 p. |
artikel |
46 |
Handling of patient dropouts in trials measuring long-term survival
|
Bhaskar, R. |
|
1984 |
5 |
3 |
p. 306- 1 p. |
artikel |
47 |
Judgment analysis in clinical trials: How to save the baby from the bathwater
|
Joyce, C.R.B. |
|
1984 |
5 |
3 |
p. 307-308 2 p. |
artikel |
48 |
Logistical considerations industries face in initiating a large-scale clinical trial
|
Kirkham, D. |
|
1984 |
5 |
3 |
p. 310- 1 p. |
artikel |
49 |
Logistics of double-blinding a randomized trial of intravenous vs. subcutaneous heparin for the treatment of venous thrombosis
|
Raskob, G. |
|
1984 |
5 |
3 |
p. 300- 1 p. |
artikel |
50 |
Longitudinal measures of compliance in the elderly
|
Greenlick, Merwyn |
|
1984 |
5 |
3 |
p. 313- 1 p. |
artikel |
51 |
Mammographic quality control in the Canadian national breast screening study (NBSS)
|
Baines, Cornelia J. |
|
1984 |
5 |
3 |
p. 295- 1 p. |
artikel |
52 |
Measuring functional outcomes in therapeutic trials for chronic disease
|
Deyo, Richard A. |
|
1984 |
5 |
3 |
p. 223-240 18 p. |
artikel |
53 |
Methodological considerations of withdrawal studies
|
Friedman, Lawrence |
|
1984 |
5 |
3 |
p. 296- 1 p. |
artikel |
54 |
Monitoring data logistics with a PC
|
Herson, Jay |
|
1984 |
5 |
3 |
p. 308- 1 p. |
artikel |
55 |
Multiple comparisons in clinical trials: How far should we go?
|
Egger, Marlene J. |
|
1984 |
5 |
3 |
p. 307- 1 p. |
artikel |
56 |
Multivariate bioassay
|
Laska, Eugene M. |
|
1984 |
5 |
3 |
p. 302- 1 p. |
artikel |
57 |
National Institutes of Health inventory of clinical trials
|
Jacoby, Itzhak |
|
1984 |
5 |
3 |
p. 298- 1 p. |
artikel |
58 |
Nonparametric procedures for comparing diagnostic tests with paired data
|
Wieand, Samuel |
|
1984 |
5 |
3 |
p. 303- 1 p. |
artikel |
59 |
Nurse practitioners in research: Untapped potential
|
Hansen, Betty |
|
1984 |
5 |
3 |
p. 294- 1 p. |
artikel |
60 |
Obtaining informed consent: Comparison of conventional and nonconventional methods
|
Stoy, D. |
|
1984 |
5 |
3 |
p. 293- 1 p. |
artikel |
61 |
On-site clinical trial data entry and check
|
Gabrieli, Christopher F.O. |
|
1984 |
5 |
3 |
p. 304- 1 p. |
artikel |
62 |
PIGAS, an interactive system for data management and data analysis of clinical trials
|
Jan, P. |
|
1984 |
5 |
3 |
p. 304- 1 p. |
artikel |
63 |
Planning, conducting and evaluating multicenter clinical trials in Germany— The view of a biometric center
|
Koepcke, Wolfgang |
|
1984 |
5 |
3 |
p. 298- 1 p. |
artikel |
64 |
Pooling trial results
|
Jesdinsky, Hans J. |
|
1984 |
5 |
3 |
p. 307- 1 p. |
artikel |
65 |
Program on the surgical control of the hyperlipidemias (POSCH): Variability in lesion assessment in single and serial paired coronary arteriograms
|
Fitch, Laurie L. |
|
1984 |
5 |
3 |
p. 291- 1 p. |
artikel |
66 |
Quality control in postmarketing epidemiologic studies
|
Luscombe, F.A. |
|
1984 |
5 |
3 |
p. 312- 1 p. |
artikel |
67 |
Rapid safety monitoring in phase I clinical trials of new antiepileptic drugs via a computer-based method
|
Valakas, Antonia M. |
|
1984 |
5 |
3 |
p. 312- 1 p. |
artikel |
68 |
Sample size and duration of follow-up for stratified clinical trials
|
Bauer, Madeline |
|
1984 |
5 |
3 |
p. 305- 1 p. |
artikel |
69 |
Selection of adequate response variables and their evaluation in rheumatology trials
|
Zwingers, Thomas |
|
1984 |
5 |
3 |
p. 295-296 2 p. |
artikel |
70 |
Site visits in a multicenter ophthalmic clinical trial
|
Cassel, Gary H. |
|
1984 |
5 |
3 |
p. 251-262 12 p. |
artikel |
71 |
Sponsor dos and don'ts—The MIAMI lesson
|
Lorstad, Mats H. |
|
1984 |
5 |
3 |
p. 298- 1 p. |
artikel |
72 |
Statistics in practice
|
Buyse, Marc |
|
1984 |
5 |
3 |
p. 315-316 2 p. |
artikel |
73 |
Success in changing established medication dosing schedules in a clinical trial
|
Probstfield, Jeffrey L. |
|
1984 |
5 |
3 |
p. 306- 1 p. |
artikel |
74 |
Table-driven identification checks in multicenter clinical trials—principles and implementation
|
Alamercery, Y. |
|
1984 |
5 |
3 |
p. 310- 1 p. |
artikel |
75 |
Testing hypotheses in clinical trials
|
Lynch, Cornelius J. |
|
1984 |
5 |
3 |
p. 301- 1 p. |
artikel |
76 |
The clinical trial outline
|
Leon, Judith M. |
|
1984 |
5 |
3 |
p. 311- 1 p. |
artikel |
77 |
The compassionate use protocol as a reseach tool
|
Rodel, Philip V. |
|
1984 |
5 |
3 |
p. 310- 1 p. |
artikel |
78 |
The effect of varying the number of response categories in a likert-type scale on response rate
|
Birkett, Nicholas John |
|
1984 |
5 |
3 |
p. 299- 1 p. |
artikel |
79 |
The impact of screening sensitivity on sample size requirements for cancer prevention trials
|
Patterson, Blossom H. |
|
1984 |
5 |
3 |
p. 305-306 2 p. |
artikel |
80 |
The importance of (A) rapid data processing and (B) randomization in phase II trials of cytotoxics in oncology illustrated by the trials of an analogue of cisplatin
|
P. A'Hern, Roger |
|
1984 |
5 |
3 |
p. 302- 1 p. |
artikel |
81 |
The prism adaptation trial design: A two-level randomization scheme to address three questions
|
Connett, John E. |
|
1984 |
5 |
3 |
p. 299- 1 p. |
artikel |
82 |
The program on the surgical control of the hyperlipidemias: Final sample size
|
Matts, John |
|
1984 |
5 |
3 |
p. 295- 1 p. |
artikel |
83 |
The use of one-sided tests of significance in clinical trials
|
Lan, K.K.Gordon |
|
1984 |
5 |
3 |
p. 299- 1 p. |
artikel |
84 |
Ticlopidine aspirin stroke study
|
Kamm, Barbara |
|
1984 |
5 |
3 |
p. 298- 1 p. |
artikel |
85 |
Unblinding and debriefing participants in a clinical trial
|
Southam, Mary A. |
|
1984 |
5 |
3 |
p. 311-312 2 p. |
artikel |
86 |
Use of the logistic model in the design of intervention studies
|
Neaton, James D. |
|
1984 |
5 |
3 |
p. 297- 1 p. |
artikel |
87 |
Using case-control data to estimate sample sizes required for disease prevention trials in high-risk groups
|
Green, Sylvan B. |
|
1984 |
5 |
3 |
p. 305- 1 p. |
artikel |
88 |
Using clinical opinion in the design of fixed-sized trials
|
Freedman, Laurence S. |
|
1984 |
5 |
3 |
p. 302- 1 p. |
artikel |
89 |
Verification of prognastic factors in multicenter clinical trials
|
Diener, M.D. |
|
1984 |
5 |
3 |
p. 309- 1 p. |
artikel |
90 |
Veterans administration cooperative study of disulfiram in the treatment of alcoholism: Study design and methodological considerations
|
Fuller, Richard K. |
|
1984 |
5 |
3 |
p. 263-273 11 p. |
artikel |
91 |
What happens to study dropouts?
|
Cramer, Joyce A. |
|
1984 |
5 |
3 |
p. 307- 1 p. |
artikel |
92 |
Who should code cause of death in a clinical trial?
|
Remington, Richard D. |
|
1984 |
5 |
3 |
p. 241-244 4 p. |
artikel |